Abstract:Background Hepatocellular carcinoma (HCC) is the second-highest cause of malignancy-related death worldwide, and many physiological and pathological processes, including cancer, are regulated by microRNAs (miRNAs). miR-193a-3p is an anti-oncogene that plays an important part in health and disease biology by interacting with specific targets and signals. Methods In vitro assays were performed to explore the influences of miR-193a-3p on the propagation and apoptosis of HCC cells. The sequencing data for HCC were obtained from The Cancer Genome Atlas (TCGA), and the expression levels of miR-193a-3p in HCC and non-HCC tissues were calculated. The differential expression of miR-193a-3p in HCC was presented as standardized mean difference (SMD) with 95% confidence intervals (CIs) in Stata SE. The impact of miR-193a-3p on the prognoses of HCC patients was determined by survival analysis. The potential targets of miR-193a-3p were then predicted using miRWalk 2.0 and subjected to enrichment analyses, including Gene Ontology (GO) annotation, Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis, and Protein-Protein Interaction (PPI) network analysis. The interaction between miR-193a-3p and one predicted target, Cyclin D1 (CCND1), was verified by dual luciferase reporter assays and Pearson correlation analysis. Results MiR-193a-3p inhibited the propagation and facilitated the apoptosis of HCC cells in vitro. The pooled SMD indicated that miR-193a-3p had a low level of expression in HCC (SMD: −0.88, 95% CI [−2.36 −0.59]). Also, HCC patients with a higher level of miR-193a-3p expression tended to have a favorable overall survival (OS: HR = 0.7, 95% CI [0.43–1.13], P = 0.14). For the KEGG pathway analysis, the most related pathway was “proteoglycans in cancer”, while the most enriched GO term was “protein binding”. The dual luciferase reporter assays demonstrated the direct interaction between miR-193a-3p and CCND1, and the Pearson correlation analysis suggested that miR-193a-3p was negatively correlated with CCND1 in HCC tissues (R = − 0.154, P = 0.002). Conclusion miR-193a-3p could suppress proliferation and promote apoptosis by targeting CCND1 in HCC cells. Further, miR-193a-3p can be used as a promising biomarker for the diagnosis and treatment of HCC in the future.

MicroRNA-212-3p Inhibits the Proliferation and Invasion of Human Hepatocellular Carcinoma Cells by Suppressing CTGF Expression

MicroRNA‐122 Suppresses Cell Proliferation and Induces Cell Apoptosis in Hepatocellular Carcinoma by Directly Targeting Wnt/β‐catenin Pathway

MicroRNA-302d Downregulates TGFBR2 Expression and Promotes Hepatocellular Carcinoma Growth and Invasion.

MiR-148b Suppresses Cell Proliferation and Invasion in Hepatocellular Carcinoma by Targeting WNT1/β-catenin Pathway

MicroRNA-181c suppresses growth and metastasis of hepatocellular carcinoma by modulating NCAPG

MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.

Mir-200A Suppresses Cell Growth and Migration by Targeting MACC1 and Predicts Prognosis in Hepatocellular Carcinoma.

Mir-654-3p Predicts the Prognosis of Hepatocellular Carcinoma and Inhibits the Proliferation, Migration, and Invasion of Cancer Cells

Downregulation of Mir-193A-3p is Involved in the Pathogenesis of Hepatocellular Carcinoma by Targeting CCND1

MicroRNA Mir-124-3p Suppresses Proliferation and Epithelial–mesenchymal Transition of Hepatocellular Carcinoma Via ARRDC1 (arrestin Domain Containing 1)

MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma.

MicroRNA-206 Overexpression Promotes Apoptosis, Induces Cell Cycle Arrest and Inhibits the Migration of Human Hepatocellular Carcinoma HepG2 Cells.

MiR-302c Inhibits Tumor Growth of Hepatocellular Carcinoma by Suppressing the Endothelial-Mesenchymal Transition of Endothelial Cells.

MicroRNA-199 Suppresses Cell Proliferation, Migration and Invasion by Downregulating RGS17 in Hepatocellular Carcinoma.

Microrna-141 Inhibits Cell Proliferation and Invasion and Promotes Apoptosis by Targeting Hepatocyte Nuclear Factor-3Β in Hepatocellular Carcinoma Cells

Mir-24-3p Suppresses Cellar Proliferation In Hepatocellular Carcinoma

MicroRNA-33a-3p suppresses cell migration and invasion by directly targeting PBX3 in human hepatocellular carcinoma.

Mir-612 Suppresses the Invasive-Metastatic Cascade in Hepatocellular Carcinoma.

Microrna-519 Suppresses Cell Growth And Invasion By Reducing Hur Levels In Hepatocellular Carcinoma

Mir-346 Suppresses Cell Proliferation Through Smyd3 Dependent Approach in Hepatocellular Carcinoma

Mir-663A Inhibits Hepatocellular Carcinoma Cell Proliferation and Invasion by Targeting HMGA2.